Thursday 13 December 2007 - ...742457 — A novel treatment to delay the symptoms of Alzheimer’s disease : Alzheimer’s disease is a devastating neurological condition, with significant consequences on the quality of life for sufferers and their care givers. GSK has a broad programme of research ongoing in Alzheimer’s disease, including 742457, a novel treatment that selectively targets the 5HT6 receptors concentrated within the brain. These receptors are associated with learning and memory... GSK's Press Release -
